Fludarabine phosphate for the treatment of low grade lymphoid malignancy
about
Protein crystallography and infectious diseases.Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma.Cost-minimization analysis of CHOP, fludarabine and rituximab for the treatment of relapsed indolent B-cell non-Hodgkin's lymphoma in the U.K.Management of chronic lymphocytic leukaemia.Fludarabine in alkylator-resistant follicular non-Hodgkin's lymphoma.Traditional treatment approaches in B-cell non-Hodgkin's lymphoma.Neurological illness following treatment with fludarabine.Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine.Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis.The newer purine analogs. Significant therapeutic advance in the management of lymphoid malignancies.Purine analogs in lymphoproliferative disorders.Bone marrow transplantation in low-grade non-Hodgkin's lymphoma.Low-grade non-Hodgkin's lymphoma--development of a new effective combination regimen (fludarabine, mitoxantrone and dexamethasone; FND).The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.
P2860
Q30419162-0E106924-1807-471D-B846-EAE1FF28442CQ33504540-99A1D810-0CEA-4CAB-A2D8-C3C388727E44Q33709700-DCBC1A3C-A07B-40B2-8CD0-E1DB2AD279C2Q33873273-C600FA07-45AA-493C-867C-E7C5419708BFQ34244545-818E4848-3E7D-427C-9735-EBEC11132FA4Q35778923-4FA3FC4E-F888-4E3C-A7A7-252DC3FB914EQ36080144-20C0994C-3E38-44D6-9778-A7B2D3C47086Q39643067-80AA8681-3A2F-4223-9A65-96B4AFFD3709Q40397753-554C27AE-D3DA-4CE4-95B9-C15F4A2C16CDQ40539671-C75910C5-7D47-4D7A-A88E-4D62EE07D5B4Q40618712-B2D1FFFE-8B47-4373-86DE-9F5AEDF86819Q40621426-ED596FB6-A223-44C0-9A06-9BF5AFF1DE57Q40958067-6D29A684-2E9D-4E8B-B38F-8933D1D9B1E9Q41699546-408DD0E1-90DA-44A4-9F2B-E3FFE7DB3A86Q45135612-BDEC1CE9-5D4E-4E7A-BC25-74453E4CEF53Q45141158-853C7B9A-E6A9-4855-AFB2-B827178D9461
P2860
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@ast
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@en
type
label
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@ast
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@en
prefLabel
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@ast
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@en
P2093
P2860
P356
P1476
Fludarabine phosphate for the treatment of low grade lymphoid malignancy
@en
P2093
A Z Rohatiner
J S Whelan
T A Lister
P2860
P2888
P304
P356
10.1038/BJC.1991.253
P407
P577
1991-07-01T00:00:00Z